SMAD2 and hepatocellular carcinoma: Our research shows that Smurf2 could inhibit EMT of HCC by increasing the degradation and ubiquitination of Smad2, which reveals a new mechanism of Smurf2 in the development of HCC and provides an effective target for the treatment of HCC.